Global Lung Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Lung Cancer Diagnostics market size was valued at USD 1938 million in 2023 and is forecast to a readjusted size of USD 2805.4 million by 2030 with a CAGR of 5.4% during review period.
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Lung Cancer Diagnostics industry chain, the market status of Industrial (Immunoassays, Flow Cytometry), Healthcare (Immunoassays, Flow Cytometry), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Lung Cancer Diagnostics.
Regionally, the report analyzes the Lung Cancer Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Lung Cancer Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Lung Cancer Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Lung Cancer Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunoassays, Flow Cytometry).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Lung Cancer Diagnostics market.
Regional Analysis: The report involves examining the Lung Cancer Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Lung Cancer Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Lung Cancer Diagnostics:
Company Analysis: Report covers individual Lung Cancer Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Lung Cancer Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Industrial, Healthcare).
Technology Analysis: Report covers specific technologies relevant to Lung Cancer Diagnostics. It assesses the current state, advancements, and potential future developments in Lung Cancer Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Lung Cancer Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Lung Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Lung Cancer Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Cancer Diagnostics, with revenue, gross margin and global market share of Lung Cancer Diagnostics from 2019 to 2024.
Chapter 3, the Lung Cancer Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Lung Cancer Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Diagnostics.
Chapter 13, to describe Lung Cancer Diagnostics research findings and conclusion.
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Lung Cancer Diagnostics industry chain, the market status of Industrial (Immunoassays, Flow Cytometry), Healthcare (Immunoassays, Flow Cytometry), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Lung Cancer Diagnostics.
Regionally, the report analyzes the Lung Cancer Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Lung Cancer Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Lung Cancer Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Lung Cancer Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunoassays, Flow Cytometry).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Lung Cancer Diagnostics market.
Regional Analysis: The report involves examining the Lung Cancer Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Lung Cancer Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Lung Cancer Diagnostics:
Company Analysis: Report covers individual Lung Cancer Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Lung Cancer Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Industrial, Healthcare).
Technology Analysis: Report covers specific technologies relevant to Lung Cancer Diagnostics. It assesses the current state, advancements, and potential future developments in Lung Cancer Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Lung Cancer Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Lung Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Immunoassays
- Flow Cytometry
- Rapid Tests
- Molecular Assays
- Tissue Arrays
- Circulating Tumor Cells
- Pharmacodiagnostics
- Biomarkers
- Other
- Industrial
- Healthcare
- Other
- Roche Diagnostics
- BioMйrieux
- Qiagen
- Advpharma
- AIT Austrian Institute of Technology
- Courtagen Life Sciences
- DiagnoCure
- BioMark Diagnostics
- Mayo Clinic
- HalioDx SAS
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Lung Cancer Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Cancer Diagnostics, with revenue, gross margin and global market share of Lung Cancer Diagnostics from 2019 to 2024.
Chapter 3, the Lung Cancer Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Lung Cancer Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Diagnostics.
Chapter 13, to describe Lung Cancer Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Lung Cancer Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lung Cancer Diagnostics by Type
1.3.1 Overview: Global Lung Cancer Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Lung Cancer Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Immunoassays
1.3.4 Flow Cytometry
1.3.5 Rapid Tests
1.3.6 Molecular Assays
1.3.7 Tissue Arrays
1.3.8 Circulating Tumor Cells
1.3.9 Pharmacodiagnostics
1.3.10 Biomarkers
1.3.11 Other
1.4 Global Lung Cancer Diagnostics Market by Application
1.4.1 Overview: Global Lung Cancer Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Industrial
1.4.3 Healthcare
1.4.4 Other
1.5 Global Lung Cancer Diagnostics Market Size & Forecast
1.6 Global Lung Cancer Diagnostics Market Size and Forecast by Region
1.6.1 Global Lung Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Lung Cancer Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business
2.1.3 Roche Diagnostics Lung Cancer Diagnostics Product and Solutions
2.1.4 Roche Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Diagnostics Recent Developments and Future Plans
2.2 BioMйrieux
2.2.1 BioMйrieux Details
2.2.2 BioMйrieux Major Business
2.2.3 BioMйrieux Lung Cancer Diagnostics Product and Solutions
2.2.4 BioMйrieux Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioMйrieux Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Lung Cancer Diagnostics Product and Solutions
2.3.4 Qiagen Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 Advpharma
2.4.1 Advpharma Details
2.4.2 Advpharma Major Business
2.4.3 Advpharma Lung Cancer Diagnostics Product and Solutions
2.4.4 Advpharma Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Advpharma Recent Developments and Future Plans
2.5 AIT Austrian Institute of Technology
2.5.1 AIT Austrian Institute of Technology Details
2.5.2 AIT Austrian Institute of Technology Major Business
2.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product and Solutions
2.5.4 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AIT Austrian Institute of Technology Recent Developments and Future Plans
2.6 Courtagen Life Sciences
2.6.1 Courtagen Life Sciences Details
2.6.2 Courtagen Life Sciences Major Business
2.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Product and Solutions
2.6.4 Courtagen Life Sciences Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Courtagen Life Sciences Recent Developments and Future Plans
2.7 DiagnoCure
2.7.1 DiagnoCure Details
2.7.2 DiagnoCure Major Business
2.7.3 DiagnoCure Lung Cancer Diagnostics Product and Solutions
2.7.4 DiagnoCure Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 DiagnoCure Recent Developments and Future Plans
2.8 BioMark Diagnostics
2.8.1 BioMark Diagnostics Details
2.8.2 BioMark Diagnostics Major Business
2.8.3 BioMark Diagnostics Lung Cancer Diagnostics Product and Solutions
2.8.4 BioMark Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BioMark Diagnostics Recent Developments and Future Plans
2.9 Mayo Clinic
2.9.1 Mayo Clinic Details
2.9.2 Mayo Clinic Major Business
2.9.3 Mayo Clinic Lung Cancer Diagnostics Product and Solutions
2.9.4 Mayo Clinic Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Mayo Clinic Recent Developments and Future Plans
2.10 HalioDx SAS
2.10.1 HalioDx SAS Details
2.10.2 HalioDx SAS Major Business
2.10.3 HalioDx SAS Lung Cancer Diagnostics Product and Solutions
2.10.4 HalioDx SAS Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 HalioDx SAS Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lung Cancer Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Lung Cancer Diagnostics by Company Revenue
3.2.2 Top 3 Lung Cancer Diagnostics Players Market Share in 2023
3.2.3 Top 6 Lung Cancer Diagnostics Players Market Share in 2023
3.3 Lung Cancer Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Lung Cancer Diagnostics Market: Region Footprint
3.3.2 Lung Cancer Diagnostics Market: Company Product Type Footprint
3.3.3 Lung Cancer Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lung Cancer Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Lung Cancer Diagnostics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Lung Cancer Diagnostics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Lung Cancer Diagnostics Market Size by Country
6.3.1 North America Lung Cancer Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Lung Cancer Diagnostics Market Size by Country
7.3.1 Europe Lung Cancer Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Lung Cancer Diagnostics Market Size by Country
9.3.1 South America Lung Cancer Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Lung Cancer Diagnostics Market Drivers
11.2 Lung Cancer Diagnostics Market Restraints
11.3 Lung Cancer Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lung Cancer Diagnostics Industry Chain
12.2 Lung Cancer Diagnostics Upstream Analysis
12.3 Lung Cancer Diagnostics Midstream Analysis
12.4 Lung Cancer Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Lung Cancer Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lung Cancer Diagnostics by Type
1.3.1 Overview: Global Lung Cancer Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Lung Cancer Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Immunoassays
1.3.4 Flow Cytometry
1.3.5 Rapid Tests
1.3.6 Molecular Assays
1.3.7 Tissue Arrays
1.3.8 Circulating Tumor Cells
1.3.9 Pharmacodiagnostics
1.3.10 Biomarkers
1.3.11 Other
1.4 Global Lung Cancer Diagnostics Market by Application
1.4.1 Overview: Global Lung Cancer Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Industrial
1.4.3 Healthcare
1.4.4 Other
1.5 Global Lung Cancer Diagnostics Market Size & Forecast
1.6 Global Lung Cancer Diagnostics Market Size and Forecast by Region
1.6.1 Global Lung Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Lung Cancer Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Lung Cancer Diagnostics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business
2.1.3 Roche Diagnostics Lung Cancer Diagnostics Product and Solutions
2.1.4 Roche Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Diagnostics Recent Developments and Future Plans
2.2 BioMйrieux
2.2.1 BioMйrieux Details
2.2.2 BioMйrieux Major Business
2.2.3 BioMйrieux Lung Cancer Diagnostics Product and Solutions
2.2.4 BioMйrieux Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioMйrieux Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Lung Cancer Diagnostics Product and Solutions
2.3.4 Qiagen Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 Advpharma
2.4.1 Advpharma Details
2.4.2 Advpharma Major Business
2.4.3 Advpharma Lung Cancer Diagnostics Product and Solutions
2.4.4 Advpharma Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Advpharma Recent Developments and Future Plans
2.5 AIT Austrian Institute of Technology
2.5.1 AIT Austrian Institute of Technology Details
2.5.2 AIT Austrian Institute of Technology Major Business
2.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product and Solutions
2.5.4 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AIT Austrian Institute of Technology Recent Developments and Future Plans
2.6 Courtagen Life Sciences
2.6.1 Courtagen Life Sciences Details
2.6.2 Courtagen Life Sciences Major Business
2.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Product and Solutions
2.6.4 Courtagen Life Sciences Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Courtagen Life Sciences Recent Developments and Future Plans
2.7 DiagnoCure
2.7.1 DiagnoCure Details
2.7.2 DiagnoCure Major Business
2.7.3 DiagnoCure Lung Cancer Diagnostics Product and Solutions
2.7.4 DiagnoCure Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 DiagnoCure Recent Developments and Future Plans
2.8 BioMark Diagnostics
2.8.1 BioMark Diagnostics Details
2.8.2 BioMark Diagnostics Major Business
2.8.3 BioMark Diagnostics Lung Cancer Diagnostics Product and Solutions
2.8.4 BioMark Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BioMark Diagnostics Recent Developments and Future Plans
2.9 Mayo Clinic
2.9.1 Mayo Clinic Details
2.9.2 Mayo Clinic Major Business
2.9.3 Mayo Clinic Lung Cancer Diagnostics Product and Solutions
2.9.4 Mayo Clinic Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Mayo Clinic Recent Developments and Future Plans
2.10 HalioDx SAS
2.10.1 HalioDx SAS Details
2.10.2 HalioDx SAS Major Business
2.10.3 HalioDx SAS Lung Cancer Diagnostics Product and Solutions
2.10.4 HalioDx SAS Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 HalioDx SAS Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lung Cancer Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Lung Cancer Diagnostics by Company Revenue
3.2.2 Top 3 Lung Cancer Diagnostics Players Market Share in 2023
3.2.3 Top 6 Lung Cancer Diagnostics Players Market Share in 2023
3.3 Lung Cancer Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Lung Cancer Diagnostics Market: Region Footprint
3.3.2 Lung Cancer Diagnostics Market: Company Product Type Footprint
3.3.3 Lung Cancer Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lung Cancer Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Lung Cancer Diagnostics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Lung Cancer Diagnostics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Lung Cancer Diagnostics Market Size by Country
6.3.1 North America Lung Cancer Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Lung Cancer Diagnostics Market Size by Country
7.3.1 Europe Lung Cancer Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Lung Cancer Diagnostics Market Size by Country
9.3.1 South America Lung Cancer Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lung Cancer Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Lung Cancer Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Lung Cancer Diagnostics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Lung Cancer Diagnostics Market Drivers
11.2 Lung Cancer Diagnostics Market Restraints
11.3 Lung Cancer Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lung Cancer Diagnostics Industry Chain
12.2 Lung Cancer Diagnostics Upstream Analysis
12.3 Lung Cancer Diagnostics Midstream Analysis
12.4 Lung Cancer Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Lung Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Lung Cancer Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Lung Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Lung Cancer Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 6. Roche Diagnostics Major Business
Table 7. Roche Diagnostics Lung Cancer Diagnostics Product and Solutions
Table 8. Roche Diagnostics Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Diagnostics Recent Developments and Future Plans
Table 10. BioMйrieux Company Information, Head Office, and Major Competitors
Table 11. BioMйrieux Major Business
Table 12. BioMйrieux Lung Cancer Diagnostics Product and Solutions
Table 13. BioMйrieux Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioMйrieux Recent Developments and Future Plans
Table 15. Qiagen Company Information, Head Office, and Major Competitors
Table 16. Qiagen Major Business
Table 17. Qiagen Lung Cancer Diagnostics Product and Solutions
Table 18. Qiagen Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Qiagen Recent Developments and Future Plans
Table 20. Advpharma Company Information, Head Office, and Major Competitors
Table 21. Advpharma Major Business
Table 22. Advpharma Lung Cancer Diagnostics Product and Solutions
Table 23. Advpharma Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Advpharma Recent Developments and Future Plans
Table 25. AIT Austrian Institute of Technology Company Information, Head Office, and Major Competitors
Table 26. AIT Austrian Institute of Technology Major Business
Table 27. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product and Solutions
Table 28. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. AIT Austrian Institute of Technology Recent Developments and Future Plans
Table 30. Courtagen Life Sciences Company Information, Head Office, and Major Competitors
Table 31. Courtagen Life Sciences Major Business
Table 32. Courtagen Life Sciences Lung Cancer Diagnostics Product and Solutions
Table 33. Courtagen Life Sciences Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Courtagen Life Sciences Recent Developments and Future Plans
Table 35. DiagnoCure Company Information, Head Office, and Major Competitors
Table 36. DiagnoCure Major Business
Table 37. DiagnoCure Lung Cancer Diagnostics Product and Solutions
Table 38. DiagnoCure Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. DiagnoCure Recent Developments and Future Plans
Table 40. BioMark Diagnostics Company Information, Head Office, and Major Competitors
Table 41. BioMark Diagnostics Major Business
Table 42. BioMark Diagnostics Lung Cancer Diagnostics Product and Solutions
Table 43. BioMark Diagnostics Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. BioMark Diagnostics Recent Developments and Future Plans
Table 45. Mayo Clinic Company Information, Head Office, and Major Competitors
Table 46. Mayo Clinic Major Business
Table 47. Mayo Clinic Lung Cancer Diagnostics Product and Solutions
Table 48. Mayo Clinic Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Mayo Clinic Recent Developments and Future Plans
Table 50. HalioDx SAS Company Information, Head Office, and Major Competitors
Table 51. HalioDx SAS Major Business
Table 52. HalioDx SAS Lung Cancer Diagnostics Product and Solutions
Table 53. HalioDx SAS Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. HalioDx SAS Recent Developments and Future Plans
Table 55. Global Lung Cancer Diagnostics Revenue (USD Million) by Players (2019-2024)
Table 56. Global Lung Cancer Diagnostics Revenue Share by Players (2019-2024)
Table 57. Breakdown of Lung Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Lung Cancer Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Lung Cancer Diagnostics Players
Table 60. Lung Cancer Diagnostics Market: Company Product Type Footprint
Table 61. Lung Cancer Diagnostics Market: Company Product Application Footprint
Table 62. Lung Cancer Diagnostics New Market Entrants and Barriers to Market Entry
Table 63. Lung Cancer Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Lung Cancer Diagnostics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Lung Cancer Diagnostics Consumption Value Share by Type (2019-2024)
Table 66. Global Lung Cancer Diagnostics Consumption Value Forecast by Type (2025-2030)
Table 67. Global Lung Cancer Diagnostics Consumption Value by Application (2019-2024)
Table 68. Global Lung Cancer Diagnostics Consumption Value Forecast by Application (2025-2030)
Table 69. North America Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Lung Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Lung Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Lung Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Lung Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Lung Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Lung Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Lung Cancer Diagnostics Raw Material
Table 100. Key Suppliers of Lung Cancer Diagnostics Raw Materials
Table 1. Global Lung Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Lung Cancer Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Lung Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Lung Cancer Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 6. Roche Diagnostics Major Business
Table 7. Roche Diagnostics Lung Cancer Diagnostics Product and Solutions
Table 8. Roche Diagnostics Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Diagnostics Recent Developments and Future Plans
Table 10. BioMйrieux Company Information, Head Office, and Major Competitors
Table 11. BioMйrieux Major Business
Table 12. BioMйrieux Lung Cancer Diagnostics Product and Solutions
Table 13. BioMйrieux Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioMйrieux Recent Developments and Future Plans
Table 15. Qiagen Company Information, Head Office, and Major Competitors
Table 16. Qiagen Major Business
Table 17. Qiagen Lung Cancer Diagnostics Product and Solutions
Table 18. Qiagen Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Qiagen Recent Developments and Future Plans
Table 20. Advpharma Company Information, Head Office, and Major Competitors
Table 21. Advpharma Major Business
Table 22. Advpharma Lung Cancer Diagnostics Product and Solutions
Table 23. Advpharma Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Advpharma Recent Developments and Future Plans
Table 25. AIT Austrian Institute of Technology Company Information, Head Office, and Major Competitors
Table 26. AIT Austrian Institute of Technology Major Business
Table 27. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product and Solutions
Table 28. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. AIT Austrian Institute of Technology Recent Developments and Future Plans
Table 30. Courtagen Life Sciences Company Information, Head Office, and Major Competitors
Table 31. Courtagen Life Sciences Major Business
Table 32. Courtagen Life Sciences Lung Cancer Diagnostics Product and Solutions
Table 33. Courtagen Life Sciences Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Courtagen Life Sciences Recent Developments and Future Plans
Table 35. DiagnoCure Company Information, Head Office, and Major Competitors
Table 36. DiagnoCure Major Business
Table 37. DiagnoCure Lung Cancer Diagnostics Product and Solutions
Table 38. DiagnoCure Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. DiagnoCure Recent Developments and Future Plans
Table 40. BioMark Diagnostics Company Information, Head Office, and Major Competitors
Table 41. BioMark Diagnostics Major Business
Table 42. BioMark Diagnostics Lung Cancer Diagnostics Product and Solutions
Table 43. BioMark Diagnostics Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. BioMark Diagnostics Recent Developments and Future Plans
Table 45. Mayo Clinic Company Information, Head Office, and Major Competitors
Table 46. Mayo Clinic Major Business
Table 47. Mayo Clinic Lung Cancer Diagnostics Product and Solutions
Table 48. Mayo Clinic Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Mayo Clinic Recent Developments and Future Plans
Table 50. HalioDx SAS Company Information, Head Office, and Major Competitors
Table 51. HalioDx SAS Major Business
Table 52. HalioDx SAS Lung Cancer Diagnostics Product and Solutions
Table 53. HalioDx SAS Lung Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. HalioDx SAS Recent Developments and Future Plans
Table 55. Global Lung Cancer Diagnostics Revenue (USD Million) by Players (2019-2024)
Table 56. Global Lung Cancer Diagnostics Revenue Share by Players (2019-2024)
Table 57. Breakdown of Lung Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Lung Cancer Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Lung Cancer Diagnostics Players
Table 60. Lung Cancer Diagnostics Market: Company Product Type Footprint
Table 61. Lung Cancer Diagnostics Market: Company Product Application Footprint
Table 62. Lung Cancer Diagnostics New Market Entrants and Barriers to Market Entry
Table 63. Lung Cancer Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Lung Cancer Diagnostics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Lung Cancer Diagnostics Consumption Value Share by Type (2019-2024)
Table 66. Global Lung Cancer Diagnostics Consumption Value Forecast by Type (2025-2030)
Table 67. Global Lung Cancer Diagnostics Consumption Value by Application (2019-2024)
Table 68. Global Lung Cancer Diagnostics Consumption Value Forecast by Application (2025-2030)
Table 69. North America Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Lung Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Lung Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Lung Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Lung Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Lung Cancer Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Lung Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Lung Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Lung Cancer Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Lung Cancer Diagnostics Raw Material
Table 100. Key Suppliers of Lung Cancer Diagnostics Raw Materials
LIST OF FIGURES
Figure 1. Lung Cancer Diagnostics Picture
Figure 2. Global Lung Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Lung Cancer Diagnostics Consumption Value Market Share by Type in 2023
Figure 4. Immunoassays
Figure 5. Flow Cytometry
Figure 6. Rapid Tests
Figure 7. Molecular Assays
Figure 8. Tissue Arrays
Figure 9. Circulating Tumor Cells
Figure 10. Pharmacodiagnostics
Figure 11. Biomarkers
Figure 12. Other
Figure 13. Global Lung Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 14. Lung Cancer Diagnostics Consumption Value Market Share by Application in 2023
Figure 15. Industrial Picture
Figure 16. Healthcare Picture
Figure 17. Other Picture
Figure 18. Global Lung Cancer Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Lung Cancer Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Market Lung Cancer Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 21. Global Lung Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 22. Global Lung Cancer Diagnostics Consumption Value Market Share by Region in 2023
Figure 23. North America Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East and Africa Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Lung Cancer Diagnostics Revenue Share by Players in 2023
Figure 29. Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 30. Global Top 3 Players Lung Cancer Diagnostics Market Share in 2023
Figure 31. Global Top 6 Players Lung Cancer Diagnostics Market Share in 2023
Figure 32. Global Lung Cancer Diagnostics Consumption Value Share by Type (2019-2024)
Figure 33. Global Lung Cancer Diagnostics Market Share Forecast by Type (2025-2030)
Figure 34. Global Lung Cancer Diagnostics Consumption Value Share by Application (2019-2024)
Figure 35. Global Lung Cancer Diagnostics Market Share Forecast by Application (2025-2030)
Figure 36. North America Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 37. North America Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 38. North America Lung Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 40. Canada Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 41. Mexico Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 42. Europe Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 43. Europe Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 44. Europe Lung Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 46. France Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 47. United Kingdom Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 48. Russia Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 49. Italy Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Lung Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 53. China Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 56. India Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 60. South America Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 61. South America Lung Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East and Africa Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 65. Middle East and Africa Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 66. Middle East and Africa Lung Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 67. Turkey Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 68. Saudi Arabia Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 69. UAE Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 70. Lung Cancer Diagnostics Market Drivers
Figure 71. Lung Cancer Diagnostics Market Restraints
Figure 72. Lung Cancer Diagnostics Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Manufacturing Cost Structure Analysis of Lung Cancer Diagnostics in 2023
Figure 75. Manufacturing Process Analysis of Lung Cancer Diagnostics
Figure 76. Lung Cancer Diagnostics Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source
Figure 1. Lung Cancer Diagnostics Picture
Figure 2. Global Lung Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Lung Cancer Diagnostics Consumption Value Market Share by Type in 2023
Figure 4. Immunoassays
Figure 5. Flow Cytometry
Figure 6. Rapid Tests
Figure 7. Molecular Assays
Figure 8. Tissue Arrays
Figure 9. Circulating Tumor Cells
Figure 10. Pharmacodiagnostics
Figure 11. Biomarkers
Figure 12. Other
Figure 13. Global Lung Cancer Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 14. Lung Cancer Diagnostics Consumption Value Market Share by Application in 2023
Figure 15. Industrial Picture
Figure 16. Healthcare Picture
Figure 17. Other Picture
Figure 18. Global Lung Cancer Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Lung Cancer Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Market Lung Cancer Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 21. Global Lung Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 22. Global Lung Cancer Diagnostics Consumption Value Market Share by Region in 2023
Figure 23. North America Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East and Africa Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Lung Cancer Diagnostics Revenue Share by Players in 2023
Figure 29. Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 30. Global Top 3 Players Lung Cancer Diagnostics Market Share in 2023
Figure 31. Global Top 6 Players Lung Cancer Diagnostics Market Share in 2023
Figure 32. Global Lung Cancer Diagnostics Consumption Value Share by Type (2019-2024)
Figure 33. Global Lung Cancer Diagnostics Market Share Forecast by Type (2025-2030)
Figure 34. Global Lung Cancer Diagnostics Consumption Value Share by Application (2019-2024)
Figure 35. Global Lung Cancer Diagnostics Market Share Forecast by Application (2025-2030)
Figure 36. North America Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 37. North America Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 38. North America Lung Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 40. Canada Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 41. Mexico Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 42. Europe Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 43. Europe Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 44. Europe Lung Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 46. France Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 47. United Kingdom Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 48. Russia Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 49. Italy Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Lung Cancer Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 53. China Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 56. India Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 60. South America Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 61. South America Lung Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East and Africa Lung Cancer Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 65. Middle East and Africa Lung Cancer Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 66. Middle East and Africa Lung Cancer Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 67. Turkey Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 68. Saudi Arabia Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 69. UAE Lung Cancer Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 70. Lung Cancer Diagnostics Market Drivers
Figure 71. Lung Cancer Diagnostics Market Restraints
Figure 72. Lung Cancer Diagnostics Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Manufacturing Cost Structure Analysis of Lung Cancer Diagnostics in 2023
Figure 75. Manufacturing Process Analysis of Lung Cancer Diagnostics
Figure 76. Lung Cancer Diagnostics Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source
